diphenyldiselenide has been researched along with C gattii Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benelli, JL; Klafke, GB; Munhoz, LS; Poester, VR; Stevens, DA; Xavier, MO | 1 |
| Al-Hatmi, AMS; Alves, SH; de Azevedo, MI; Loreto, ES; Rossato, L; Santurio, JM; Venturini, TP | 1 |
2 other study(ies) available for diphenyldiselenide and C gattii Infection
| Article | Year |
|---|---|
In vitro anti-Cryptococcus activity of diphenyl diselenide alone and in combination with amphotericin B and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2021 |
In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Topics: Amphotericin B; Antifungal Agents; Benzene Derivatives; Cryptococcosis; Cryptococcus; Drug Synergism; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Organoselenium Compounds | 2019 |